Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death
Authors:
- R. NaRNR. Na
- S.L. ZhengSZS.L. Zheng
- M. HanMHM. Han
- H. YuHYH. Yu
- D. JiangDJD. Jiang
- S. ShahSSS. Shah
- C. EwingCEC. Ewing
- L. ZhangLZL. Zhang
- K. NovakovicKNK. Novakovic
- J. PetkewiczJPJ. Petkewicz
- K. GulukotaKGK. Gulukota
- D. HelsethDHD. Helseth
- 1 March 2017
- journal article
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e832-e833